| A bump in the road: how the hostile AML microenvironment affects CAR T cell therapy R Epperly, S Gottschalk, MP Velasquez Frontiers in oncology 10, 262, 2020 | 64 | 2020 |
| CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells N Hebbar, R Epperly, A Vaidya, U Thanekar, SE Moore, M Umeda, J Ma, ... Nature Communications 13 (1), 587, 2022 | 50 | 2022 |
| Harnessing T cells to target pediatric acute myeloid leukemia: CARs, BiTEs, and beyond R Epperly, S Gottschalk, MP Velasquez Children 7 (2), 14, 2020 | 21 | 2020 |
| Infectious complications in pediatric, adolescent and young adult patients undergoing CD19-CAR T cell therapy GM Maron, DR Hijano, R Epperly, Y Su, L Tang, RT Hayden, S Naik, ... Frontiers in oncology 12, 845540, 2022 | 14 | 2022 |
| Treatment of pediatric plasma cell myeloma type post‐transplant lymphoproliferative disorder with modern risk‐directed therapy R Epperly, J Ozolek, K Soltys, D Cohen, R Goyal, E Friehling Pediatric Blood & Cancer 65 (10), e27283, 2018 | 6 | 2018 |
| Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML T Pfeiffer, Y Li, E Ashcraft, SE Karol, JE Rubnitz, R Epperly, R Madden, ... Bone Marrow Transplantation 58 (3), 328-331, 2023 | 5 | 2023 |
| Improving the evaluation and management of abnormal uterine bleeding in female adolescents presenting for emergency care AG Close, GM Sequeira, GT Montano, LJ Alessi, MC McCormick, ... Journal of pediatric and adolescent gynecology 32 (2), 128-134, 2019 | 5 | 2019 |
| Secondary hemophagocytic syndrome after autologous hematopoietic cell transplant and immune therapy for neuroblastoma R Epperly, W Furman, M Hines, T Santiago, Y Li, R Madden, E Mamcarz, ... Pediatric Blood & Cancer 66 (11), e27964, 2019 | 4 | 2019 |
| CD45RA-depleted haploidentical transplantation combined with NK cell addback results in promising long-term outcomes in pediatric patients with high-risk hematologic malignancies S Naik, AC Talleur, Y Li, RM Madden, E Mamcarz, A Qudeimat, A Sharma, ... Blood 138, 172, 2021 | 3 | 2021 |
| Targeting plasma cells with daratumumab aids in the treatment of post‐transplant autoimmune‐like hepatitis R Epperly, T Santiago, CE Morin, K Patton, J Deyo, J Eshun, B Triplett, ... Pediatric Blood & Cancer 68 (11), e29290, 2021 | 3 | 2021 |
| Nutrition management of pediatric patients undergoing hematopoietic stem cell transplantation: Guidelines, gaps, and research K Ringwald‐Smith, H Hillman, K Gibbons, R Epperly Nutrition in Clinical Practice 38 (4), 731-747, 2023 | 2 | 2023 |
| Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients R Epperly, AC Talleur, Y Li, S Schell, MC Tuggle, JY Métais, S Huang, ... Transplantation and cellular therapy 28 (5), 262. e1-262. e10, 2022 | 2 | 2022 |
| CD45RO+ T-Cell Add Back and Prophylactic Blinatumomab Administration Post Tcrαβ/CD19-Depleted Haploidentical Transplantation in Pediatric Patients with High Risk Acute Leukemia S Naik, RM Madden, E Mamcarz, A Srinivasan, A Sharma, AC Talleur, ... Blood 138, 2897, 2021 | 2 | 2021 |
| Long-term follow-up of CD19-CAR T-cell therapy in children and young adults with B-ALL R Epperly, NN Shah Hematology 2023 (1), 77-83, 2023 | 1 | 2023 |
| Venetoclax-Based Combination Therapy As a Bridge to Allogeneic Hematopoietic Stem Cell Transplant in Children with Relapsed/Refractory AML. T Pfeiffer, Y Li, SE Karol, JE Rubnitz, R Epperly, R Madden, E Mamcarz, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | 1 | 2022 |
| GRP78 Is expressed on the cell surface of pediatric AML blasts and can be targeted with GRP78-CAR T cells without toxicity to hematopoietic progenitor cells N Hebbar, R Epperly, A Vaidya, S Huang, C Cheng, S Gottschalk, ... Blood 136, 12, 2020 | 1 | 2020 |
| Multi-Omic Based Antigen Discovery for the Immunotherapy of Pediatric Acute T Cell Lymphoblastic Leukemia N Hebbar, C Qu, H Wang, Y Shao, P Nguyen, A Freiwan, R Epperly, Y Li, ... Blood 136, 17-18, 2020 | 1 | 2020 |
| Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia Y Petgrave, S Selukar, R Epperly, S Naik, NDL Santos, BM Triplett, ... Pediatric Nephrology, 1-9, 2024 | | 2024 |
| CAR T Cells redirected to B7-H3 for pediatric Solid Tumors: Current Status and Future Perspectives R Epperly, S Gottschalk, C DeRenzo EJC Paediatric Oncology, 100160, 2024 | | 2024 |
| Disease Status and Interval between HCTs Predict Outcome of Pediatric Patients who Undergo a Subsequent HCT for Relapsed Hematologic Malignancy R Epperly, Y Li, S Selukar, E Zeng, R Madden, E Mamcarz, S Naik, ... Transplantation and Cellular Therapy, 2024 | | 2024 |
